What we found on the web about Heparans
CypA mediates HIV-1 attachment to target cells via heparans. In the search for CypA-binding sites on target cells, we found that CypA binds directly to heparans.
The endothelial cells lining the capillaries are the source of heparans, the body's natural blood thinners. When fibrin coats these cells, the heparans cannot be released, reducing ...
Binding of Recombinant Feline Immunodeficiency Virus Surface Glycoprotein to Feline Cells: Role of CXCR4, Cell-Surface Heparans, and an Unidentified Non-CXCR4 Receptor
Saphire, A.C.S., Bobardt, M.D., Gallay,P.A. (1999) Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO Journal 18(23):6771-6785
These heparans activate AT. AT is a slow inhibitor of thrombin, but in the presence of heparin, AT reacts 1000 times faster. This is the reason heparin is used as a drug in ...
1: J Virol. 2001 May;75(10):4528-39. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an ...
Normally, when the endothelial cells release heparans, the release activates the AT, which acts slowly to reduce the thrombin. Not enough AT may be produced, or ...
The endothelial cells lining the capillaries are the source of heparans, the body's natural blood thinners. When fibrin coats these cells, the heparans cannot be released, reducing ...
The binding specifically occurs to a core pentasaccharide present both in the heparans and in their therapeutic derivative heparin. The accompanying conformational change of ...
Here is what users have to say about Heparans

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!